The analyst's Medical Devices sector report, “Arteriotomy Closure Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update" provides comprehensive information about the Arteriotomy Closure Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Arteriotomy closure devices are used to achieve the hemostasis of an arterial puncture site after an angiography procedure, percutaneous coronary intervention or a peripheral intervention. Arteriotomy closure devices are used to decrease vascular complications and reduce the time to hemostasis and ambulation compared to the traditional methods such as manual or mechanical compression.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Arteriotomy closure devices are used to achieve the hemostasis of an arterial puncture site after an angiography procedure, percutaneous coronary intervention or a peripheral intervention. Arteriotomy closure devices are used to decrease vascular complications and reduce the time to hemostasis and ambulation compared to the traditional methods such as manual or mechanical compression.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Arteriotomy Closure Devices under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Arteriotomy Closure Devices and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
Reasons to Buy
The report enables you to :
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
- Identify and understand important and diverse types of Arteriotomy Closure Devices under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date
Table of Contents
1 Table of Contents
2 Introduction
3 Products under Development
4 Arteriotomy Closure Devices - Pipeline Products under Development by Companies
5 Arteriotomy Closure Devices Companies and Product Overview
6 Arteriotomy Closure Devices- Recent Developments
7 Appendix
List of Tables
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Aporo Biomedical, Inc. (Inactive)
- Arterica Inc
- CardioDex Ltd (Inactive)
- CaveoMed GmbH
- CloSys Corp
- CPC of America Inc
- CyndRX LLC
- Dextera Surgical Inc
- Genesis MedTech International Pvt Ltd
- Harvard University
- Lepu Medical Technology (Beijing) Co Ltd
- Nanjing SealMed Medical Technology Corp Ltd
- NewMed Medical Co Ltd
- ProMed Inc
- Rex Medical LP
- Shanghai HeartCare Medical Technology Co Ltd
- Spiorad Medical Ltd
- Terumo Interventional Systems
- University of Rochester
- Vascular Closure Systems Inc
- Vivasure Medical Ltd.
- Zylox-Tonbridge Medical Technology Co Ltd
